AUTOLUS THERAPEUTICS P
3.2700
27-November-24 15:45:00
15 minutes delayed
Stocks
+0.1750
+5.65%
Today's range
3.1300 - 3.3900
ISIN
N/A
Source
NASDAQ
-
18 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
06 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces publication in Cancer Immunology Research
27 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
20 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
16 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
Autolus to hold Annual General Meeting (AGM) of Shareholders on Friday, June 30, 2023
06 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
02 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
22 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
12 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress
04 May 2023 06:00:02 By Nasdaq GlobeNewswire
-
27 Apr 2023 06:01:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner
27 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Publication in Molecular Therapy Nucleic Acids
26 Apr 2023 15:01:00 By Nasdaq GlobeNewswire
-
26 Apr 2023 06:06:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics to Host Virtual Capital Markets Day
25 Apr 2023 06:00:01 By Nasdaq GlobeNewswire
-
20 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Publication in Molecular Therapy
04 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces resignation of Chief Financial Officer
14 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Has No Business Relationship with Silicon Valley Bank
13 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Full Year 2022 Financial Results and Operational Progress
07 Mar 2023 06:00:01 By Nasdaq GlobeNewswire